Skip to content

Ginkgo Bioworks DNA Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$11.37B+8.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.1B+100.0%
TEC
Bio-TechneTECH
$8.26B-13.6%
Azenta logo
AzentaAZTA
$903.8M
Regenxbio logo
RegenxbioRGNX
$488.35M+58.6%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's enterprise value?
Ginkgo Bioworks (DNA) reported enterprise value of $601.63M in Q1 2026.
How has Ginkgo Bioworks's enterprise value changed year-over-year?
Ginkgo Bioworks's enterprise value increased by 46.8% year-over-year, from $409.95M to $601.63M.
What is the long-term trend for Ginkgo Bioworks's enterprise value?
Over 4 years (2021 to 2025), Ginkgo Bioworks's enterprise value has grown at a -50.8% compound annual growth rate (CAGR), from $12.5B to $731.02M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.